Page 27 - Formulation News Today

Bristol Myers Squibb has announced it has acquired Karuna Therapeutics, Inc., for a total equity value of $14 billion or $12.7 billion net of estimated cash.

India-based Morning Fresh is actively expanding its portfolio across categories and formats to fulfil rising demand for functional products, particularly ready-to-drink (RTD) beverages.

Celadon Pharmaceuticals has today (December 14) announced its first supply of it pharmaceutical-grade breakthrough cannabis-based medicine.

A portfolio company created and incubated by Apple Tree Partners (ATP) has raised $52 million in series A funding to enable it to rapidly discover novel small molecule therapeutics.

There is a widespread, unmet demand for products to support gut health among athletes and active lifestyle consumers, with almost nine out of 10 sports people suffering from gut problems.

Biotech company SolasCure has announced the results of its proof-of-concept phase 2 trial investigating its wound gel for chronic venous leg ulcer patients.

Infants who were fed on a novel milk formula containing large milk phospholipids coated droplets in the first four months of life were found to have a body mass index (BMI) and blood pressure that were similar to breastfed infants, according to a five-year follow-up study by Danone.

A treatment option to reduce the number and intensity of hot flashes and night sweats associated with menopause has been approved by the European Commission (EC).

Pharma and plant-based ingredient giant, Roquette, has confirmed its acquisition of Qualicaps from the Mitsubishu Chemical Group.

Eli Lilly has invested in its manufacturing capacity once more and has announced plans to build a $2.5 billion high-tech manufacturing site in Germany.